NCT02486367View on ClinicalTrials.gov

Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions

Aortic StenosisInflammationThrombosis

Interventions

DRUG

Clopidogrel

Standard ADP receptor blockade

DRUG

Ticagrelor

High potency ADP receptor blockade

Trial Locations (1)

44106

UH Cleveland Medical Center, Cleveland

All Listed Sponsors

lead

University Hospitals Cleveland Medical Center

OTHER

NCT02486367 - Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR) | Biotech Hunter | Biotech Hunter